Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000245871 | SCV000304801 | benign | not specified | 2018-03-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000245871 | SCV000523399 | benign | not specified | 2016-02-24 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV001795405 | SCV002049301 | benign | not provided | 2023-11-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002057372 | SCV002437475 | benign | RYR1-related disorder | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002494712 | SCV002803148 | likely benign | Central core myopathy; Malignant hyperthermia, susceptibility to, 1; Congenital multicore myopathy with external ophthalmoplegia; Congenital myopathy with fiber type disproportion; King Denborough syndrome | 2021-08-11 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001795405 | SCV005310887 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000245871 | SCV001922834 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000245871 | SCV001956601 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001795405 | SCV002035971 | likely benign | not provided | no assertion criteria provided | clinical testing |